ACEPRE, LLC
Develop natural compound emodin as a novel therapy for calcific aortic valve disease
Develop natural compound emodin as a novel therapy for calcific aortic valve disease is a funding opportunity from ACEPRE, LLC, up to 299953, closing September 16, 2026.
Sep 16, 2026
(47d left)Overview
Summary: Calcific aortic valve disease (CAVD) is a progressive heart disease ranging from aortic valve sclerosis to aortic valve stenosis, characterized by severe calcification with impaired leaflet function. CAVD affects 25% of the population over 65 years of age and about 50% of those over 85 years old. Male sex is…